ALTAMIR_REGISTRATION_DOCUMENT_2017

Presentation of the Company 1 PRESENTATION OF THE COMPANY AND ITS ACTIVITIES

26.9 Residual cost in €m

29.8 Fair value in €m

3.3 % of the portfolio at fair value

HEALTHCARE – 8 other companies

Annual turnover (in millions of euros)

Company

Country

Business description

Unilabs is a leading pan-European diagnostics company, providing laboratory and radiology services to public and private healthcare providers (hospitals, GPs, occupational health units), county councils, insurance companies and outpatients, as well as to the pharmaceutical industry and clinical research organisations. Unilabs is active in 12 countries (Denmark, Finland, France, Italy, Norway, Portugal, Spain, Sweden, Switzerland, the UK, UAE and Peru) with strong market positions in Switzerland, France, Iberia and Scandinavia. The laboratory business generates over 80% of EBITDA, mainly from France, Switzerland and Scandinavia, and the medical imaging business generates the remainder. Syneron Candela is a leading global non-surgical aesthetic device company based in Israel and the United States. The company provides advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, women’s intimate health, improving the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite.

805

Switzerland

www.unilabs.fr

240*

United States

www.syneron-candela. com

Vyaire Medical is a carve-out of the Respiratory Solutions Business of US group Becton Dickinson. Vyaire Medical is the world leader in respiratory diagnostics, ventilation and post-anaesthesia monitoring.

668*

United States

www.vyaire.com

NuPharm365 is a leading generic pharmaceuticals company focused on treatments for central nervous system disorders. The company was formed in 2016 from the merger of Neuraxpharm Arzneimittel in Germany and Invent Farma in Spain.

Germany

193

www.nupharm.com

Spain

* Revenue converted into millions of euros based on exchange rates prevailing on 31 December 2017.

40 REGISTRATION DOCUMENT

• ALTAMIR 2017

www.altamir.fr